Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2018 18:59 ET | Source: Taiwan Liposome Company, Ltd.

TLC Announces Application with U.S. FDA for Proceeding of TLC590 as Investigational New Drug (IND)

TAIPEI, Taiwan, April 03, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO) (“TLC”), a clinical-stage specialty pharmaceutical company dedicated to the development and...